CLINICAL TRIALS PROFILE FOR ATROPINE SULFATE

All Clinical Trials for ATROPINE SULFATE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00121524 ↗	Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) Outcome	Completed	Health Region East, Norway	Phase 2	2003-01-01	Intravenous epinephrine has been part of the guidelines for cardiopulmonary resuscitation since the start. It improves outcome in animal studies, but has never been investigated in a controlled study in humans. Epidemiologic data indicate that it is an independent negative predictor for survival. If this is true in a controlled randomized study, it could be due to effects of the drug itself or more likely due to reduced quality of chest compressions and ventilations due to the time spent on placing an I.V. needle and injecting drugs.
NCT00121524 ↗	Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) Outcome	Completed	Laerdal Medical	Phase 2	2003-01-01	Intravenous epinephrine has been part of the guidelines for cardiopulmonary resuscitation since the start. It improves outcome in animal studies, but has never been investigated in a controlled study in humans. Epidemiologic data indicate that it is an independent negative predictor for survival. If this is true in a controlled randomized study, it could be due to effects of the drug itself or more likely due to reduced quality of chest compressions and ventilations due to the time spent on placing an I.V. needle and injecting drugs.
NCT00121524 ↗	Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) Outcome	Completed	Norwegian Air Ambulance Foundation	Phase 2	2003-01-01	Intravenous epinephrine has been part of the guidelines for cardiopulmonary resuscitation since the start. It improves outcome in animal studies, but has never been investigated in a controlled study in humans. Epidemiologic data indicate that it is an independent negative predictor for survival. If this is true in a controlled randomized study, it could be due to effects of the drug itself or more likely due to reduced quality of chest compressions and ventilations due to the time spent on placing an I.V. needle and injecting drugs.
NCT00121524 ↗	Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) Outcome	Completed	Ullevaal University Hospital	Phase 2	2003-01-01	Intravenous epinephrine has been part of the guidelines for cardiopulmonary resuscitation since the start. It improves outcome in animal studies, but has never been investigated in a controlled study in humans. Epidemiologic data indicate that it is an independent negative predictor for survival. If this is true in a controlled randomized study, it could be due to effects of the drug itself or more likely due to reduced quality of chest compressions and ventilations due to the time spent on placing an I.V. needle and injecting drugs.
NCT00121524 ↗	Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) Outcome	Completed	University of Oslo	Phase 2	2003-01-01	Intravenous epinephrine has been part of the guidelines for cardiopulmonary resuscitation since the start. It improves outcome in animal studies, but has never been investigated in a controlled study in humans. Epidemiologic data indicate that it is an independent negative predictor for survival. If this is true in a controlled randomized study, it could be due to effects of the drug itself or more likely due to reduced quality of chest compressions and ventilations due to the time spent on placing an I.V. needle and injecting drugs.
NCT00121524 ↗	Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) Outcome	Completed	Petter Andreas Steen	Phase 2	2003-01-01	Intravenous epinephrine has been part of the guidelines for cardiopulmonary resuscitation since the start. It improves outcome in animal studies, but has never been investigated in a controlled study in humans. Epidemiologic data indicate that it is an independent negative predictor for survival. If this is true in a controlled randomized study, it could be due to effects of the drug itself or more likely due to reduced quality of chest compressions and ventilations due to the time spent on placing an I.V. needle and injecting drugs.
NCT00458003 ↗	Phenylephrine in Spinal Anesthesia in Preeclamptic Patients	Completed	Northwestern University	N/A	2006-07-01	Hypotension remains a common clinical problem after induction of spinal anesthesia for cesarean delivery. Maternal hypotension has been associated with considerable morbidity (maternal nausea and vomiting and fetal/neonatal acidemia). Traditionally, ephedrine has been the vasopressor of choice because of concerns about phenylephrine's potential adverse effect on uterine blood flow. This practice was based on animal studies which showed that ephedrine maintained cardiac output and uterine blood flow, while direct acting vasoconstrictors, e.g., phenylephrine, decreased uteroplacental perfusion. However, several recent studies have demonstrated that phenylephrine has similar efficacy to ephedrine for preventing and treating hypotension and may be associated with a lower incidence of fetal acidosis. All of these studies have been performed in healthy patients undergoing elective cesarean delivery. Preeclampsia complicates 5-6% of all pregnancies and is a significant contributor to maternal and fetal morbidity and mortality. Many preeclamptic patients require cesarean delivery of the infant. These patients often have uteroplacental insufficiency. Given the potential for significant hypotension after spinal anesthesia and its effect on an already compromised fetus, prevention of (relative) hypotension in preeclamptic patients is important. Spinal anesthesia in preeclamptic patients has been shown to have no adverse neonatal outcomes as compared to epidural anesthesia when hypotension is treated adequately. Due to problems related to management of the difficult airway and coagulopathy, both of which are more common in preeclamptic women, spinal anesthesia may be the preferred regional anesthesia technique. Recent studies have demonstrated that preeclamptic patients may experience less hypotension after spinal anesthesia than their healthy counterparts. To our knowledge, phenylephrine for the treatment of spinal anesthesia-induced hypotension has not been studied in women with preeclampsia. The aim of our study is to compare intravenous infusion regimens of phenylephrine versus ephedrine for the treatment of spinal anesthesia induced hypotension in preeclamptic patients undergoing cesarean delivery. The primary outcome variable is umbilical artery pH.

Clinical Trial Conditions for ATROPINE SULFATE

Condition Name

Condition Name for ATROPINE SULFATE
Intervention	Trials
Postoperative Pain	6
Myopia	5
Myopia, Progressive	3
Pain, Postoperative	3

Condition MeSH

Condition MeSH for ATROPINE SULFATE
Intervention	Trials
Pain, Postoperative	8
Myopia	8
Myopia, Degenerative	3
Bradycardia	3

Clinical Trial Locations for ATROPINE SULFATE

Trials by Country

Trials by Country for ATROPINE SULFATE
Location	Trials
United States	52
Egypt	11
Brazil	4
China	4
Austria	3

Trials by US State

Trials by US State for ATROPINE SULFATE
Location	Trials
Texas	7
California	5
North Carolina	3
Colorado	3
South Carolina	3

Clinical Trial Progress for ATROPINE SULFATE

Clinical Trial Phase

Clinical Trial Phase for ATROPINE SULFATE
Clinical Trial Phase	Trials
Phase 4	9
Phase 3	6
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for ATROPINE SULFATE
Clinical Trial Phase	Trials
Completed	25
Not yet recruiting	10
Recruiting	8

Clinical Trial Sponsors for ATROPINE SULFATE

Sponsor Name

Sponsor Name for ATROPINE SULFATE
Sponsor	Trials
Mansoura University	4
Assiut University	3
Ain Shams University	3

Sponsor Type

Sponsor Type for ATROPINE SULFATE
Sponsor	Trials
Other	57
Industry	15
U.S. Fed	3